Mbd3

Weekend Reads: Cool Papers, PubPeer, Jacob Hanna, & More

journals1

Here are some papers and news for weekend reads. What are you reading this weekend? What are your go-to stem cell journals? Hostile Takeover: Glioma Stem Cells Recruit TAMs to Support Tumor Progression by Yu Shi, Yi-fang Ping, Xia Zhang, Xiu-wu Bian in Cell Stem Cell. YAP1 Regulates OCT4 Activity and SOX2 Expression to Facilitate self-renewal and […]

Weekend Reads: Cool Papers, PubPeer, Jacob Hanna, & More Read More »

Silva Comments on MBD3/NuRD Debate with Jacob Hanna

Jose-Silva

What’s the deal with the tension between José Silva and Jacob Hanna over pluripotency? Researchers probing how to reprogram cells into powerful stem cells (induced pluripotent stem cells or IPSCs) and what the molecular mechanisms are behind this process have become entangled in a conflict. Of course over the years scientists including stem cell scientists have

Silva Comments on MBD3/NuRD Debate with Jacob Hanna Read More »

Jacob Hanna on Radically Deterministic Reprogramming @TMM2013

When Jacob Hanna  says “radically deterministic” cellular reprogramming, what does he mean? Jacob Hanna’s lab recently published a very high profile Nature paper on nearly 100% efficient iPS cell formation based on targeting a factor called Mbd3. This super efficiency is a major departure from past reported efficiencies. This morning here at the Till &

Jacob Hanna on Radically Deterministic Reprogramming @TMM2013 Read More »

100% reprogramming efficiency reports Jacob Hanna

A team at the Weizmann Institute of Science in Israel led by Jacob Hanna reports today near perfect reprogramming efficiency to make induced pluripotent stem cells (iPSCs) by eliminating a single factor called Mbd3 from the cellular equation. On first glance, the Nature article (Rais, et al.) seems to be all about boosting cellular reprogramming efficiency to close

100% reprogramming efficiency reports Jacob Hanna Read More »

Subscribe to Our Newsletter

Be the first to know about the latest developments in stem cell and regenerative medicine research.